SecBot SecBot
6-K ·Filed Aug 10, 2026

ACB

AURORA CANNABIS INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001279569-26-000760
Notable filing: 6-K
Actionable Insight • Neutral

No immediate trading catalyst from this filing. Monitor next quarterly earnings (expected in November 2026) for operational and financial updates. The high board approval and say-on-pay support indicate no shareholder dissent, but the stock remains subject to cannabis sector volatility and regulatory developments.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
ACB ▲ +33.91% at T+20d
NEUTRAL call +33.91% · α vs SPY +34.82% · entry $2.89 → $3.87
Next anchor: T+60d in 7d
Latest observation: T+53 +54.36% FF3 residual α
Entry = T+0 close
Aug 10, 2026
via day close
T+1d
+20.59%
call +20.59% · α +20.91%
$3.49
settled 3mo ago
T+5d
+24.57%
call +24.57% · α +24.61%
$3.60
settled 2mo ago
T+20d
+33.91%
call +33.91% · α +34.82%
$3.87
settled 7w ago
T+60d
Pending
in 7d

Price Chart

Loading chart...

Executive Summary

Aurora Cannabis Inc. filed a 6-K reporting the results of its 2026 Annual General Meeting held on August 7, 2026. All five director nominees were elected with over 85% of votes cast in favor, Ernst & Young LLP was appointed as auditor, and the advisory 'Say-on-Pay' resolution passed with 82.97% approval. The filing is a routine governance update with no material financial or operational disclosures.

Key Facts

  • All five director nominees received >85% votes for (Miguel Martin 85.12%, Michael Singer 86.34%, Chitwant Kohli 86.10%, Norma Beauchamp 86.52%, Rajesh Uttamchandani 85.98%).
  • Shareholders approved Ernst & Young LLP as auditor for the ensuing year.
  • Advisory vote on executive compensation ('Say-on-Pay') passed with 82.97% of votes FOR.
  • Total shares represented at the meeting were 16,639,306 common shares, representing 26.86% of outstanding shares.

Financial Impact

No financial impact; routine governance filing.

Risk Factors

  • No material risks identified from this filing; broader risks include cannabis regulatory changes and competitive pressures.

Market Snapshot

Exchange
Nasdaq
Sector
Medicinal Chemicals & Botanical Products
Analyst Consensus
60% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001279569-26-000760
Document: aurora_6k.htm0001279569-26-000760
Document: 0001279569-26-000760-index-headers.html0001279569-26-000760
Document: 0001279569-26-000760-index.html0001279569-26-000760
Document: 0001279569-26-000760.txt0001279569-26-000760
29 reports for ACB
Performance horizon
50% Hit rate @ T+5 4 of 8 directional calls Went positive at some point 5 of 8 best @ T+5▲ +3.26%Apr 15, 2026
Filters
Rows
Reports for ACB — sortable, filterable
TypeNow
Oct 26, 2026
today
6-K
NEUTRAL ★ 4/10
$3.87awaiting T+5—$3.90 (+0.78%)
Oct 14, 2026
12d ago
6-K
NEUTRAL ★ 6/10
$4.10 $3.97▼ −3.17%▼ −2.16%$3.90 (−4.88%)
Oct 8, 2026
19d ago
6-K
NEUTRAL ★ 4/10
$4.43 $4.10▼ −7.45%▼ −7.17%$3.90 (−11.96%)
Oct 6, 2026
20d ago
6-K
NEUTRAL ★ 6/10
$4.46 $4.17▼ −6.50%▼ −5.52%$3.90 (−12.56%)
Oct 5, 2026
21d ago
6-K
NEUTRAL ★ 5/10
$4.59 $4.29▼ −6.54%▼ −6.40%$3.90 (−15.03%)
Sep 16, 2026
5w ago
6-K
NEUTRAL ★ 4/10
$3.83 $4.22▲ +10.18%▲ +7.62%$3.90 (+1.83%)
Sep 14, 2026
6w ago
6-K
NEUTRAL ★ 5/10
$3.81 $4.03▲ +5.77%▲ +5.67%$3.90 (+2.36%)
Sep 9, 2026
6w ago
6-K
NEUTRAL ★ 3/10
$3.88 $3.83▼ −1.29%▼ −0.63%$3.90 (+0.52%)
Sep 2, 2026
7w ago
6-K
BULLISH ★ 7/10
$4.03 $3.73▼ −7.44%▼ −6.49%$3.90 (−3.23%)
Aug 24, 2026
9w ago
6-K
NEUTRAL ★ 5/10
$3.94 $4.05▲ +2.79%▲ +2.32%$3.90 (−1.02%)
Showing 10 of 29

US Market Status

Market Closed — Opens in 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 10, 2026